ONYX PHARMACEUTICALS INC Accretion Expense
ONYX PHARMACEUTICALS INC reported Accretion Expense of $130.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2012-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2012-11-02
- 2011-09-30: Accretion Expense 9 month $130.00K.
| Period end | Accretion Expense 9 month |
|---|---|
| 2011-09-30 | $130.00K 10-Q · filed 2012-11-02 |